Naturhouse Health (2NH) Stock Statistics & Valuation Metrics
Total Valuation
Naturhouse Health has a market cap or net worth of EUR 138.48M. The enterprise value is EUR 133.81T.
- Market Cap
- EUR 138.48M
- Enterprise Value
- EUR 133.81T
Share Statistics
Naturhouse Health has 60,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 60,000,000
- Owned by Insiders
- 77.91%
- Owned by Institutions
- 0.05%
Financial Efficiency
Naturhouse Health’s return on equity (ROE) is 0.57 and return on invested capital (ROIC) is 44.34%.
- Return on Equity (ROE)
- 0.57
- Return on Assets (ROA)
- 0.30
- Return on Invested Capital (ROIC)
- 44.34%
- Return on Capital Employed (ROCE)
- 0.62
- Revenue Per Employee
- 283.51K
- Profits Per Employee
- 60.08K
- Employee Count
- 168
- Asset Turnover
- 1.42
- Inventory Turnover
- 11.89
Valuation Ratios
The current PE Ratio of Naturhouse Health is 15.84. Naturhouse Health’s PEG ratio is -2.53.
- PE Ratio
- 15.84
- PS Ratio
- 3.07
- PB Ratio
- 8.83
- Price to FCF
- 12.85
- Price to Operating Cash Flow
- 12.73
- PEG Ratio
- -2.53
Income Statement
In the last 12 months, Naturhouse Health had revenue of 47.63M and earned 10.09M in profits. Earnings per share was 0.17.
- Revenue
- 47.63M
- Gross Profit
- 12.94M
- Operating Income
- 13.31M
- Pretax Income
- 13.70M
- Net Income
- 10.09M
- EBITDA
- 14.45M
- Earnings Per Share (EPS)
- 0.17
Cash Flow
In the last 12 months, operating cash flow was 10.61M and capital expenditures 128,000, giving a free cash flow of 10.74M billion.
- Operating Cash Flow
- 10.61M
- Free Cash Flow
- 10.74M
- Free Cash Flow per Share
- 0.18
Dividends & Yields
Naturhouse Health pays an annual dividend of ―, resulting in a dividend yield of 10.87%
- Dividend Per Share
- ―
- Dividend Yield
- 10.87%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 7.78%
- Earnings Yield
- 6.37%
Stock Price Statistics
- Beta
- 0.15
- 52-Week Price Change
- 6.60%
- 50-Day Moving Average
- 2.33
- 200-Day Moving Average
- 2.43
- Relative Strength Index (RSI)
- 52.03
- Average Volume (3m)
- 4,396
Important Dates
Naturhouse Health upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Sep 30, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Naturhouse Health as a current ratio of 1.65, with Debt / Equity ratio of 19.31%
- Current Ratio
- 1.65
- Quick Ratio
- 1.40
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -0.69
- Interest Coverage Ratio
- 151.25
Taxes
In the past 12 months, Naturhouse Health has paid 3.60M in taxes.
- Income Tax
- 3.60M
- Effective Tax Rate
- 0.26
Enterprise Valuation
Naturhouse Health EV to EBITDA ratio is 12.05, with an EV/FCF ratio of 12.46.
- EV to Sales
- 2.98
- EV to EBITDA
- 12.05
- EV to Free Cash Flow
- 12.46
- EV to Operating Cash Flow
- 12.61
Balance Sheet
Naturhouse Health has EUR 10.43M in cash and marketable securities with EUR 6.29M in debt, giving a net cash position of EUR 4.13M billion.
- Cash & Marketable Securities
- EUR 10.43M
- Total Debt
- EUR 6.29M
- Net Cash
- EUR 4.13M
- Net Cash Per Share
- EUR 0.07
- Tangible Book Value Per Share
- EUR 0.25
Margins
Gross margin is 70.90%, with operating margin of 24.01%, and net profit margin of 19.16%.
- Gross Margin
- 70.90%
- Operating Margin
- 24.01%
- Pretax Margin
- 25.72%
- Net Profit Margin
- 19.16%
- EBITDA Margin
- 24.73%
- EBIT Margin
- 24.07%
Analyst Forecast
The average price target for Naturhouse Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -6.06%
- EPS Growth Forecast
- -15.89%
